Skip to main content

FDA Approvals

Infectious Diseases, FDA Approvals

Chikungunya Vaccine Fetches FDA Nod for Persons Aged ≥12 Years

FDA Approvals, Mental Health

FDA OKs Subcutaneous Apomorphine Infusion for Parkinson’s Treatment

FDA Approvals, Pain

FDA Approves First-in-Class Option for Acute Pain

FDA Approvals, Neurology

AXS-07 Gets Nod for Acute Migraine Treatment

Biosimilars, Cardiometabolic Health, FDA Approvals

FDA OKs Rapid-Acting Insulin Biosimilar Product

In-Depth Treatment Profile, FDA Approvals, Bispecific Antibodies

Epkinly Receives Accelerated Approval for Treatment of Follicular Lymphoma After ≥2 Lines of Systemic Therapy

Rohan Vashi, PharmD, MSc

Rohan Vashi, PharmD, MSc

In-Depth Treatment Profile, A Payer Perspective, FDA Approvals, Bispecific Antibodies

Bispecific Antibody Columvi Offering Option in Diffuse Large B-cell Lymphoma Treatment

Rohan Vashi, PharmD, MSc

Rohan Vashi, PharmD, MSc

Directory of Novel FDA Approvals, 2024

FDA OKs Revumenib for Relapsed, Refractory Acute Leukemia With KMT2A Translocation

FDA OKs At-Home Influenza Vaccine

Page 1 of 53
Results 1 - 10 of 522